Drawing for NUPREVIQ

USPTO serial 79169811

NUPREVIQ

Reviewed by CopyMark Law Group

Reg. 4872533Status 706Registered
Filing date
Status date
Registration date
Dec 22, 2015
Examiner
LEHKER, DAWN FELDMAN
Law office
Historical data usage

What this means

This trademark is registered with the USPTO. Monitoring new filings can help you catch lookalike marks early.

Need help with NUPREVIQ?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Henry B. Ward, III

Henry B. Ward, III Bradley Arant Boult Cummings LLP214 North Tryon Street, Suite 3700Charlotte, NC 28202United States

Goods and services

ClassDescriptionStatusFirst use
044Medical testing of patients for determining individual risk of forming inhibitors during a hemophilia treatment with factor VIIIACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Feb 4, 2026NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Feb 4, 202671AGREGISTERED-SEC.71 ACCEPTED—
Jan 26, 2026APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Sep 29, 2025ES71TEAS SECTION 71 RECEIVED—
May 29, 2025RNWLINTERNATIONAL REGISTRATION RENEWED—
Dec 22, 2024REM4COURTESY REMINDER - SEC. 71 (10-YR) E-MAILED—
Jun 5, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Jun 5, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Jun 5, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Jul 11, 2022NA71NOTICE OF ACCEPTANCE OF SEC. 71 - E-MAILED—
Jul 11, 202271AGREGISTERED-SEC.71 ACCEPTED—
Jun 6, 2022APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
Dec 21, 2021ES71TEAS SECTION 71 RECEIVED—
Aug 19, 2016GPNXNOTIFICATION PROCESSED BY IB—
Aug 18, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 11, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Aug 11, 2016NREPNEW REPRESENTATIVE AT IB RECEIVED—
Mar 24, 2016FICSFINAL DISPOSITION NOTICE SENT TO IB—
Mar 24, 2016FIMPFINAL DISPOSITION PROCESSED—
Jan 21, 2016GPARGRANT OF PROTECTION CREATED, TO BE SENT TO IB—
Dec 22, 2015R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Oct 6, 2015PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 2, 2015GPNXNOTIFICATION PROCESSED BY IB—
Sep 24, 2015NREPNEW REPRESENTATIVE AT IB RECEIVED—
Sep 16, 2015OPNSNOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB—
Sep 16, 2015OP2RNOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB—
Sep 16, 2015NPUBNOTICE OF PUBLICATION—
Aug 31, 2015CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 27, 2015DOCKASSIGNED TO EXAMINER—
Aug 11, 2015MAFRAPPLICATION FILING RECEIPT MAILED—
Aug 6, 2015NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Jul 30, 2015REPRSN ASSIGNED FOR SECT 66A APPL FROM IB—

Frequently asked questions

Related guidance